Long-Term Efficacy of SGLT2 Inhibitors for Elderly Patients with Acute Decompensated Heart Failure: The OASIS-HF Study
The SGLT2i are not only associated with the reduction of the composite events of HF rehospitalization or cardiovascular death and protect against worsening renal function but also with a decrease in long-term repeated HF rehospitalizations.
Authors
- Tomoki Shokawa
- Yukiko Nakano (ORCID: https://orcid.org/0000-0003-1658-8219)
- Hiroki Kinoshita (ORCID: https://orcid.org/0000-0001-9700-2130)
- Michitaka Amioka (ORCID: https://orcid.org/0000-0001-5637-2709)
- Kazuhiro R. Nitta (ORCID: https://orcid.org/0000-0003-3151-0962)
- Kenichi Yamane
- Yuto Fuji
Institutions
- Hiroshima University (JP)
- Hiroshima General Hospital (JP)
- Shizuoka Medical Center (JP)
- Onomichi General Hospital (JP)
Publication Details
- Journal
- ESC Heart Failure
- Published
- 2024-09-28
- DOI
- https://doi.org/10.1002/ehf2.15088
- Citations
- 10
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 3.58